Bedside glue blepharorrhaphy for recalcitrant exposure keratopathy in immobilized patients.

June 30, 2008 · Posted in Daily Health News · Comment 

CONCLUSIONS: Bedside glue blepharorrhaphy with tissue adhesive n-butyl-2-cyanoacrylate is a practical, economic, and effective procedure in the treatment of exposure keratopathy in immobilized patients.

Read the original here:
Bedside glue blepharorrhaphy for recalcitrant exposure keratopathy in immobilized patients.

Burn during a routine pterygium excision operation.

June 30, 2008 · Posted in Daily Health News · Comment 

CONCLUSIONS: Surgeons should try to separate these three elements or eliminate any of them, in order to minimize or prevent such events. PMID: 18609490 [PubMed - indexed for MEDLINE] (Source: European Journal of Ophthalmology)

Originally posted here:
Burn during a routine pterygium excision operation.

Allergan Announces Intent To File New Drug Application For Bimatoprost As Novel Treatment To Stimulate Natural Eyelash Growth

June 5, 2008 · Posted in Daily Health News · Comment 

Allergan, Inc. (NYSE:AGN) announced that it intends to file a New Drug Application by end of the third quarter of 2008 with the U.S. Food and Drug Administration (FDA) for bimatoprost, a synthetic prostaglandin analog, as a treatment to stimulate eyelash growth.

Continue reading here:
Allergan Announces Intent To File New Drug Application For Bimatoprost As Novel Treatment To Stimulate Natural Eyelash Growth

Allergan Opens Up on Eyelash Drug

June 3, 2008 · Posted in Daily Health News · Comment 

Allergan plans to seek FDA approval for a cosmetic drug to make eyelashes grow darker, thicker and longer. (Source: WSJ.com: Health)

Read the original post:
Allergan Opens Up on Eyelash Drug